If you think about it, large numbers of patients have only been using Revlimid for six years or so; Velcade maybe seven or eight. So solid survival data is just starting to pop-up. Let me introduce you to a study, presented at ASCO, that should help shut-up the, "You need to transplant right away!" crowd.
Thursday I wrote: There are strong forces at work here, pushing hard for early transplantation. Some are economic. But it goes deeper than that. Push-back is strong and growing... If you would like to refresh your memory, here's a link back to Thursday's post: Is it reasonable to delay transplant? YES! But myeloma establishment doesn’t
A reader emailed me yesterday and asked how many subscribers/readers I have. I responded, "We are currently averaging between 1,200-1,300 page views daily." That translates into between 500-600 daily readers, best I can tell. April 5th I wrote a "catch-all" post that blows these numbers away. Almost 2,300 people have read this post in less
Here's Part Two of Ed Wolfman's multiple myeloma journey: Transplant or Not: Should I Wait? OK. So now I’m a cancer patient. What next? I took some tests with a local oncologist and I was determined to be a non-secreter. I was also ranked on the ISS staging system as a being slightly into
Most multiple myeloma patients under the age of 75--or sometimes even older--are faced with fateful decisions of if and when to undergo a stem cell transplant. An autologous stem cell transplant (SCT) is still the standard of care for patients who are healthy enough to undergo the procedure. They have become surprisingly safe and reliable.